Clinical usefulness of the CSF β-amyloid Aβ1-42/Aβ1-40 ratio for Alzheimer's disease diagnosis: a retrospective study in a Belgian academic hospital

被引：0
|
作者：
Deltombe, Matthieu [1 ,2 ]
Fillee, Catherine [1 ,2 ]
van Pesch, Vincent [3 ,4 ]
机构：
[1] Clin Univ St Luc, Dept Clin Biochem, Brussels, Belgium
[2] Catholic Univ Louvain, Brussels, Belgium
[3] Clin Univ St Luc, Dept Neurol, B-1200 Brussels, Belgium
[4] Catholic Univ Louvain, UClouvain, 10 Ave Hippocrate, B-1200 Brussels, Belgium
来源：
ACTA NEUROLOGICA BELGICA | 2022年 / 122卷 / 01期
关键词：
Alzheimer; A beta 1-42; A beta 1-40; Ratio; Cerebrospinal fluid; BIOMARKERS;
D O I：
10.1007/s13760-021-01846-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：245 / 247
页数：3
相关论文
共 50 条
  • [21] Highly specific and ultrasensitive plasma test detects Abeta(1-42) and Abeta(1-40) in Alzheimer's disease
    Thijssen, Elisabeth H.
    Verberk, Inge M. W.
    Vanbrabant, Jeroen
    Koelewijn, Anne
    Heijst, Hans
    Scheltens, Philip
    van der Flier, Wiesje
    Vanderstichele, Hugo
    Stoops, Erik
    Teunissen, Charlotte E.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Plasma betacarotene in Alzheimer's disease.: Association with cerebrospinaffluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau
    Stuerenburg, HJ
    Ganzer, S
    Müller-Thomsen, T
    NEUROENDOCRINOLOGY LETTERS, 2005, 26 (06) : 696 - 698
  • [23] Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease
    Lista, Simone
    Emanuele, Enzo
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 411 - 413
  • [24] Beta-amyloid peptides(1-42) and (1-40) in the cerebrospinal fluid during pregnancy: a prospective observational study
    Alomar-Dominguez, Cristina
    Dostal, L.
    Thaler, J.
    Putz, G.
    Humpel, C.
    Lederer, W.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2021, 24 (03) : 455 - 461
  • [25] Aggregation States of Aβ1-40, Aβ1-42 and Aβp3-42 Amyloid Beta Peptides: A SANS Study
    Festa, Giulia
    Mallamace, Francesco
    Sancesario, Giulia Maria
    Corsaro, Carmelo
    Mallamace, Domenico
    Fazio, Enza
    Arcidiacono, Laura
    Sakai, Victoria Garcia
    Senesi, Roberto
    Preziosi, Enrico
    Sancesario, Giuseppe
    Andreani, Carla
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (17)
  • [26] Amyloid beta 1-42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer's disease
    Shea, Yat Fung
    Chu, Leung-wing
    Mok, Ming-yee Maggie
    Lam, Man-Fai
    JOURNAL OF NEPHROLOGY, 2014, 27 (02) : 217 - 220
  • [27] Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease
    Park, Jong-Chan
    Han, Sun-Ho
    Yi, Dahyun
    Byun, Min Soo
    Lee, Jun Ho
    Jang, Sukjin
    Ko, Kang
    Jeon, So Yeon
    Lee, Yun-Sang
    Kim, Yu Kyeong
    Lee, Dong Young
    Mook-Jung, Inhee
    BRAIN, 2019, 142 : 771 - 786
  • [28] An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF
    DeMarco, Mari L.
    Quyen Nguyen
    Fok, Alice
    Hsiung, Ging-Yuek Robin
    van der Gugten, J. Grace
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [29] CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease
    Lista, Simone
    Garaci, Francesco G.
    Ewers, Michael
    Teipel, Stefan
    Zetterberg, Henrik
    Blennow, Kaj
    Hampel, Harald
    ALZHEIMERS & DEMENTIA, 2014, 10 (03) : 381 - 392
  • [30] Automation vs. Experience: Measuring Alzheimer's Beta-Amyloid 1-42 Peptide in the CSF
    Kollhoff, Alexander L.
    Howell, Jennifer C.
    Hu, William T.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
12345